Browse Blog Posts: Cancer Care | Lab Best Practice

Browse Topic
Cancer Care
Cancer Care

Introduction to Molecular Pathways & Routine DNA MMR Deficiency Testing in Colorectal Adenocarcinoma

Colorectal cancer is the third most common cause of cancer death in both men and women in the United States [1]. The vast majority of colorectal cancers are adenocarcinomas, which are malignancies arising from the

Read More
Cancer Care

Considering pattern of invasion to identify low risk endocervical adenocarcinomas

In economically developed countries like the U.S., the decline of endocervical squamous cell carcinoma associated with the utilization of the Pap screening test is one of the great success stories in medicine.

Read More
Cancer Care

ProMisE – a Simple and Clinically Applicable Molecular Classifier of Endometrial Cancer

Endometrial cancer (EC) is the most common gynecologic cancer in the U.S. and the 4th most common cancer in women. There are about 61,000 cases annually which account for about 7% of all cancers in women.

Read More
Blood Disorders

Assessing Platelet Refractoriness and the Appropriate Use of HLA Testing

Platelet transfusions have become a mainstay of treatment that are invaluable in the management of patients with hematologic and oncologic disorders.

Read More
Blood Disorders

A Brief Introduction to Clinical Application of Liquid Biopsy

What is liquid biopsy? It's a test done on circulating tumor cells or shed fragments of tumor DNA from a sample of blood to determine the genomics or molecular portrait of a tumor.

Read More
Cancer Care

Assessment of HER2 status in Gastroesophageal Adenocarcinoma (GEA)

Human epidermal growth factor receptor-2 (HER2) is a proto-oncogene that encodes a tyrosine kinase receptor belonging to the epidermal growth factor receptor (EGFR) family.

Read More
Cancer Care

Current Challenges for HER2 Immunohistochemistry Testing in Diagnostic Pathology

In the era of precision medicine, human epidermal growth factor receptor 2 (HER2) is one of the important predictive and prognostic biomarkers in breast cancer.

Read More
Cancer Care

Current State of Prostate Cancer Testing

Prostate cancer is one of the leading causes of cancer-related mortality among men in the U.S. Early detection and new treatments have been attributed to the excellent five-year survival rate.

Read More